LMR Partners’s Cidara Therapeutics CDTX Stock Holding History

LMR Partners’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-56,014	Closed	-$12.4M	–	1513
2025 Q4	$12.4M	Buy	+56,014	New	+$9.05M	0.02%	307
2021 Q3	–	Sell	-543	Closed	-$22K	–	1014
2021 Q2	$22K	Buy	+543	New	+$23K	﹤0.01%	1069
2017 Q3	–	Sell	-2,202	Closed	-$331K	–	347
2017 Q2	$331K	Buy	+2,202	New	+$304K	0.02%	457

LMR Partners's CDTX Position: Q1 2026 in Review

LMR Partners sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 56,014 shares — an estimated $12.4M sold.

LMR Partners first reported a position in CDTX in Q2 2017 and held it in 3 quarters. The position peaked at $12.4M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

LMR Partners reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
LMR Partners sold 56,014 Cidara Therapeutics shares in Q1 2026, an estimated $12.4M.
LMR Partners first reported a position in Cidara Therapeutics in Q2 2017 and held it in 3 quarters.
LMR Partners's Cidara Therapeutics position peaked at $12.4M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.